Flare Photometry in Uveitis Patients

ChromoLogic, LLC1 site in 1 country100 target enrollmentJune 2013

ConditionsUveitis

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Uveitis
Sponsor: ChromoLogic, LLC
Enrollment: 100
Locations: 1
Primary Endpoint: Establish OFAM algorithms for quantitation of ocular flare
Status: Completed
Last Updated: 12 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This is a cross sectional study of a novel non-invasive optical flare photometer (OFAM). Patients meeting the inclusion/exclusion criteria will receive a standard eye examination including a slit lamp examination to collect ocular flare data. In addition to the standard eye examination, subjects will receive flare measurements using the OFAM device.

Registry

clinicaltrials.gov

Start Date

June 2013

End Date

April 2014

Last Updated

12 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

ChromoLogic, LLC

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Age greater than 18 years
•Ability to understand and willingness to sign a written informed consent document.
•To be eligible for the uveitis arm of the study subjects must have active anterior chamber uveitis in one or both eyes as determined by a physician
•To be eligible for the non-inflammatory arm of the study the study subjects must have no ocular inflammation in either eye as determined by a physician.

Exclusion Criteria

•Inability to give informed consent
•Exclusion criteria for the uveitis arm: no active disease
•Exclusion criteria for the non-inflammatory arm: Signs of uveitis

Outcomes

Primary Outcomes

Establish OFAM algorithms for quantitation of ocular flare

Time Frame: 3 months

OFAM algorithms for quantitation of ocular flare will be established by comparing the output of the OFAM device to the flare measurements obtained during the standard slit lamp examination.